Generic drugmaker Lupin has received U.S. Food and Drug Administration approval for its abbreviated new drug applications for Liraglutide Injection single-patient-use prefilled pens and Glucagon for injection vials. Both the products will be manufactured at the company’s injectable facility in Nagpur, Lupin said. Liraglutide injection 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pen […]
Continue Reading
Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese market. Under the partnership that will enable Lupin to expand footprint in China, SUP will obtain regulatory approvals for selling Tiotropium DPI in China. Lupin […]
Continue Reading
While nitrosamines are common in water and various foods, these impurities may increase risk of cancer if people are exposed to them above acceptable levels over long periods of time, the company said. | Photo Credit: Reuters Lupin Pharmaceuticals Inc. is voluntarily recalling four lots of Quinapril tablets in the U.S. to the patient level. […]
Continue ReadingCopyright © 2022
Designed and Developed by Cpool Digital Learning
